(Q40382332)
Statements
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas (English)
Miguel Taron
Yukito Ichinose
Bartomeu Massuti
Jose Luis Mate
Christian Manegold
Mayumi Ono
Cristina Queralt
Thierry Jahan
Jose Javier Sanchez
Maria Sanchez-Ronco
Victor Hsue
David Jablons
Jose Miguel Sanchez
Teresa Moran